Gunderson Dettmer Stough Villeneuve Franklin & Hachigian represented Muna Therapeutics in the transaction. Muna Therapeutics, a biotechnology company focused on developing innovative therapeutics for neurodegenerative diseases,...
Muna Therapeutics’ Research Alliance with GSK
GSK’s Acquisition of CMG1A46 from Chimagen Biosciences
Appleby acted as Cayman Islands counsel to GSK Plc on the deal. GSK proposed the acquisition of full global rights to CMG1A46, a clinical-stage dual CD19...
GSK’s Acquisition of Aiolos
Cleary Gottlieb Steen & Hamilton is representing GSK plc in the transaction. SK plc (GSK) entered into an agreement on January 8, 2024 to acquire Aiolos Bio,...
GSK’s Licensing Agreement with Hansoh Pharma for HS-20093
Davis Polk & Wardwell advised GSK on the transaction. GSK plc (LSE/NYSE: GSK) and Hansoh Pharma (HKEX: 03692) announced that they have entered into an exclusive license...
GSK’s Licensing Agreement with Hansoh Pharma
Davis Polk & Wardwell advised GSK on the deal. GSK plc (LSE/NYSE: GSK) and Hansoh Pharma (HKEX: 03692) announced that they have entered into an exclusive license...
23andMe’s New Data Licensing Agreement with GSK
Davis Polk & Wardwell advised GSK on the deal. 23andMe Holding Co. (Nasdaq: ME) (“23andMe”) announced a new non-exclusive data license with GSK plc (LSE/NYSE: GSK) which...
GSK and Pfizer’s Demerger of Haleon
Wachtell, Lipton, Rosen & Katz and Clifford Chance served as Pfizer’s legal advisors, and Skadden, Arps, Slate, Meagher & Flom served as its tax advisor for...